Back
Crinetics Pharmaceuticals 10K Form
Buy
54
CRNX
Crinetics Pharmaceuticals
Last Price:
$32.33
Seasonality Move:
6.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRNX News And Ratings
See the #1 stock for the next 7 days that we like better than CRNX
CRNX Financial Statistics
Sales & Book Value
Annual Sales: | $1M |
---|---|
Cash Flow: | $-89.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $13.41 |
Price / Book: | 2.19 |
Profitability
EPS (TTM): | -3.82000 |
---|---|
Net Income (TTM): | $-328.3M |
Gross Margin: | -- |
Return on Equity: | -32.07% |
Return on Assets: | -29.06% |
Crinetics Pharmaceuticals Earnings Forecast
Key Crinetics Pharmaceuticals Financial Ratios
-
The Research & Development expenses have been 23,114.15% of Revenue.
-
The Net Earning history of CRNX is -28,720.69% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 1 years.
Crinetics Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | CRNX |
CUSIP: | 22663K |
Website: | crinetics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 22.53 |
Quick Ratio: | 22.36 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CRNX Technical Analysis vs Fundamental Analysis
Buy
54
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a BuyThe current Crinetics Pharmaceuticals [CRNX] share price is $29.37. The Score for CRNX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.